Sign in
4

Changes in Ownership

Traws Pharma, Inc. Filed Acc 0000905718-19-000596

10% owner sold 10,927 shares at an average $2.83 ($30,901)

From the SEC's structured data for this filing

Trades in this filing

TYNDALL CAPITAL PARTNERS L P · 10% owner

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-09 Sale : show line 1 in the form −8,185 $2.84 $23,204 805,249 I
2019-07-10 Sale : show line 2 in the form −2,742 $2.81 $7,697 802,507 I
Open-market sales · 10,927 sh · avg $2.83 · $30,901
Loading xslF345X03/onconova_fm4jul92019.xml…